University of North Carolina

ACTG Presents Study at CROI Elucidating Mechanism of CMV on Aging-Related Pathways in HIV

Retrieved on: 
Monday, March 4, 2024
Infection, Chairperson, Bangladesh Technical Education Board, Diabetes, CMV, Metabolism, Merck, Cancer, Endothelial dysfunction, Fungal infection, NIAID, CROI, Inflammation, Blood, IL-6, Ageing, ACTG, Splenic infarction, Risk, Conference, Cytomegalovirus, University, ART, Biomarker, Merck & Co., University of California, UM1, Insulin resistance, Poster, Letermovir, Probability, Atherosclerosis, Plasma, TNF, HIV, University of North Carolina, Immune system, Brain

CMV is a chronic and usually asymptomatic virus carried by 60 percent of adults in the general population and more than 95 percent of people living with HIV.

Key Points: 
  • CMV is a chronic and usually asymptomatic virus carried by 60 percent of adults in the general population and more than 95 percent of people living with HIV.
  • Prior to the availability of effective antiretroviral therapy (ART) for HIV, CMV caused life-threatening infections in the eyes, brain, and gut in people with compromised immune systems due to advanced HIV.
  • “Investigators have found associations between CMV and heart disease, cancer, and other aging-related complications among people living with HIV,” said ACTG Chair Judith Currier, M.D., M.Sc., University of California, Los Angeles.
  • ACTG is led by Dr. Currier and Joseph J. Eron, M.D., University of North Carolina (ACTG Vice-Chair).

Prevent Cancer Foundation awards $1 million in new research grants

Retrieved on: 
Wednesday, February 21, 2024
Head, Breast cancer, Neck, Cancer, Woman, Survivor, Diet, Reproductive medicine, Assistant, Melanoma, Blood, Uterus, Biostatistics, Skin, Immunodeficiency, Database, Communication, Risk, FACP, Breast, University, Stomach, Vaccination, MD Anderson Cancer Center, Member of Congress, Genetic, Dicarboxylic acid, Drinking, Ovarian cancer, Genetics, Squamous-cell carcinoma, Death, Associate, Genetic testing, Black, Huntsman Cancer Institute, SCCS, Disease, HPV, Knowledge, Health literacy, Mortality, New York University, Research, University of North Carolina, Partnership, Birth control

Alexandria, Va., Feb. 21, 2024 (GLOBE NEWSWIRE) -- The Prevent Cancer Foundation® is pleased to announce new funding for ten scientists who are researching cancer prevention and early detection.

Key Points: 
  • Alexandria, Va., Feb. 21, 2024 (GLOBE NEWSWIRE) -- The Prevent Cancer Foundation® is pleased to announce new funding for ten scientists who are researching cancer prevention and early detection.
  • Read on for more on the 2024 research grantees or access more detailed information on their projects in the researcher database.
  • Having a family history of cancer can affect the age at which cancer screening begins and genetic testing recommendations.
  • To view all past funded research grant and fellowship projects driving these key advancements in cancer prevention and early detection, explore the Prevent Cancer Foundation’s Award Database.

Marriott Bonvoy Celebrates Passion of Sports Fans With Game Day Rituals Campaign and Contest Ahead of NCAA March Madness Tournament

Retrieved on: 
Tuesday, February 20, 2024
University of Georgia, Rocket Mortgage FieldHouse, Restaurant, College basketball, NCAA, Key Tower, University of Colorado Boulder, University of California, Berkeley, Rock, Transport, Roam, State Farm Stadium, University of Connecticut, Game day, University of Memphis, Personality, Fairfield Inn, Food, Travel, Risk, University, Texas Tech University, Learfield, University of California, Duke University, UCLA, University of North Carolina, Hotel

BETHESDA, Md., Feb. 20, 2024 /PRNewswire/ -- Marriott Bonvoy® is celebrating its eighth year as the Official Hotel Partner of the NCAA® and the 2024 March Madness® tournament with the launch of its "Score Big with Marriott Bonvoy Game Day Rituals" campaign and contest. Marriott Bonvoy, Marriott International's extraordinary portfolio of over 30 hotel brands, award-winning travel program, and endless experiences, has a brand for every type of fan.

Key Points: 
  • Highlighting the passionate enthusiasm of sports fans, Marriott Bonvoy's "Game Day Rituals" campaign features a variety of NCAA athletes2, coaches, and fans as they prepare for games at various Marriott Bonvoy hotels.
  • "Our Game Day Rituals campaign encapsulates the exceptional travel experiences that Marriott Bonvoy provides for travelers, from sports fans to players and coaches alike," said Mandy Gill, Vice President, Continent Marketing, Marriott International.
  • Ahead of the March Madness tournament, Marriott Bonvoy hotels are gearing up to host fans and players alike for their game day getaways.
  • 1The Marriott Game Day Rituals Survey was conducted by Wakefield Research (wakefieldresearch.com) among 1,000 U.S. sports fans with a game day ritual.

ACTG Announces Launch of Clinical Trial Evaluating Drug-Drug Interaction in Shortened Tuberculosis Regimen Among People Living with HIV

Retrieved on: 
Wednesday, February 14, 2024
Infection, Bangladesh Technical Education Board, Tuberculosis, NIAID, Blood, Safety, ACTG, Trial of the century, TB, Risk, University, ART, Rifapentine, University of London, University of California, Johns Hopkins University, UM1, Pharmacokinetics, Diagnosis, Ageing, HIV, Research, University of North Carolina, Pharmaceutical industry

Previously, ACTG study A5349 demonstrated that a four-month, four-drug TB regimen that included high-dose rifapentine was as effective as the standard six-month regimen, cutting the treatment time by one third.

Key Points: 
  • Previously, ACTG study A5349 demonstrated that a four-month, four-drug TB regimen that included high-dose rifapentine was as effective as the standard six-month regimen, cutting the treatment time by one third.
  • “Understanding the relationship between these anti-TB and HIV medications is crucial, as an estimated one third of people living with HIV worldwide are at risk for developing TB,” said ACTG Chair Judith Currier, M.D., M.Sc., University of California, Los Angeles.
  • Dolutegravir is being supplied to study A5406 by ViiV Healthcare Ltd and the fixed-dose combination of dolutegravir/tenofovir disoproxil fumarate/lamivudine is being supplied by Viatris.
  • The ACTG is led by Dr. Currier and Joseph J. Eron, M.D., University of North Carolina (ACTG Vice Chair).

Rutgers Appoints 33 Research Fellows to Study a Key Gateway to Wealth for the Middle Class: Employee Share Ownership

Retrieved on: 
Tuesday, February 13, 2024
Human Resources, Labor, Consulting, Public Policy, Government, Professional Services, Philanthropy, University, Foundation, Education, Fellow, Democrat, Workplace, Cooperative, Social, Employee stock ownership, Harvard Law School, Rutgers University, History, Associate, Knowledge, Joseba Azkarraga, Past, Research, University of North Carolina, University of Minnesota

The Rutgers Institute for the Study of Employee Ownership and Profit Sharing has announced the appointment of 33 research fellows to join its global network of scholars and subject matter experts.

Key Points: 
  • The Rutgers Institute for the Study of Employee Ownership and Profit Sharing has announced the appointment of 33 research fellows to join its global network of scholars and subject matter experts.
  • They will explore business models that enable workers to build wealth on top of wages, creating new opportunities to strengthen the middle class and close racial and gender wealth gaps.
  • “These fellows are advancing understanding of employee share ownership, profit sharing, and similar tools for sharing wealth and profits, in important ways.
  • The Institute is the world’s leading academic research hub dedicated to employee share ownership, equity compensation, profit sharing, and worker cooperatives.

SSP International Announces Doubled Capacity in its Summer Science Program, Expanded Partnerships with U.S. Colleges and Increased Financial Aid

Retrieved on: 
Monday, February 12, 2024
SSP, Chapel, Indiana University, Education, Georgetown University, Southeastern Oklahoma State University, University of Colorado Boulder, Growth, Summer Science Program, Purdue University, New Mexico State University, State university system, Immersion, Face, University, Indiana University Bloomington, Genomics, Science, University of North Carolina, Biochemistry, Student, Management

NEW YORK, Feb. 12, 2024 /PRNewswire/ -- SSP International (SSP), a nonprofit offering advanced science immersion experiences to high school students through its Summer Science Program, today announced that this summer it will double the number of placements available to nearly 400 through new partnerships with Georgia College & State University, Georgetown University and Southeastern Oklahoma State University. These new partnerships will bring the total number of programs to 12 this summer, including five astrophysics programs, three biochemistry programs, three genomics programs and a first-of-its-kind synthetic chemistry program. To reach more deserving participants and increase access to high-quality science education for students historically underrepresented in STEM, the nonprofit will also offer $3,000 stipends to qualified participants who would otherwise have to work in the summer and, in turn, miss out on critical enrichment opportunities.  

Key Points: 
  • "Now operating as SSP International, we are excited to welcome the next generation of students interested in STEM to our Summer Science Program," said Frank Steslow, CEO.
  • "This year, we're especially focused on reaching and engaging individuals who would otherwise not have access to the Summer Science Program experience.
  • Summer Science Program provides programs in astrophysics, biochemistry and genomics taught through rigorous, collaborative research projects on college campuses.
  • If you are interested in applying for its 2024 Summer Science Program, you can visit this link for steps on how to apply: summerscience.org/admissions/how-to-apply .

NAfME Elects Cecil Adderley 2024-2026 National President-Elect

Retrieved on: 
Monday, February 12, 2024
University, National Association, Doctor of Philosophy, Education, Parent, Virginia University, Prince, Student, NMEA, Commonwealth, Innovation, Virginia Commonwealth University, West Virginia University, Leadership studies, Berklee College of Music, Supervisor, University of North Carolina, Southern Division, Doane University, George Mason University, Adderley, Western Carolina University, Research, Stafford County Public Schools, Virginia Coalition, Executive Committee, Music education, Teaching

HERNDON, Va., Feb. 12, 2024 /PRNewswire-PRWeb/ -- On February 9, 2024, the National Association for Music Education (NAfME) announced the 2024–2026 National President-Elect, Cecil Adderley, elected by NAfME members. Cecil Adderley is the Chair of Music Education at Berklee College of Music in Boston, Massachusetts.

Key Points: 
  • On February 9, 2024, the National Association for Music Education (NAfME) announced the 2024–2026 National President-Elect, Cecil Adderley, elected by NAfME members.
  • HERNDON, Va., Feb. 12, 2024 /PRNewswire-PRWeb/ -- On February 9, 2024, the National Association for Music Education (NAfME) announced the 2024–2026 National President-Elect, Cecil Adderley, elected by NAfME members.
  • NAfME values the contributions to music education from all the candidates who take part in this process and looks forward to Cecil Adderley carrying NAfME into the future.
  • NAfME values the contributions to music education from all the candidates who take part in this process and looks forward to Cecil Adderley carrying NAfME into the future.

Denali Therapeutics Announces New Data and Expansion of Its Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapy Programs at WORLDSymposium™

Retrieved on: 
Wednesday, February 7, 2024
Traffic barrier, Sanfilippo, Genomics, Hearing, Growth, BBB, AFL, Metabolism, Feinberg School of Medicine, Spleen, Dermatan sulfate, Patient, Cerebrospinal fluid, University of North Carolina, FDA, Cognition, COMPASS, Mouse, CSF, Physician, Hunter syndrome, MPS II, Brain, Behavior, MPS, Mucopolysaccharidosis, Hunting, University, SGSH, ETV, Liver, Alfa, Glycogen storage disease, Pharmaceutical industry

Denali’s BBB-crossing enzyme replacement approach has the potential to prevent cognitive and behavioral manifestations in MPS IIIA.

Key Points: 
  • Denali’s BBB-crossing enzyme replacement approach has the potential to prevent cognitive and behavioral manifestations in MPS IIIA.
  • New two-year peripheral biomarker data demonstrate high magnitude and sustained reduction of urine heparan sulfate and dermatan sulfate, including in participants who switched from standard-of-care enzyme replacement therapy to tividenofusp alfa, suggesting enhanced peripheral activity.
  • Denali also announced that dosing has begun in the Phase 1/2 study of DNL126 for the potential treatment of MPS IIIA.
  • “Our goal is to bring effective new medicines to MPS families as soon as possible,” said Carole Ho, M.D., Chief Medical Officer of Denali.

Season 2 of "Car Wash Convos™" Features Texas Men's Basketball Forward Brock Cunningham

Retrieved on: 
Tuesday, January 30, 2024
University of Memphis, App Store (iOS/iPadOS), University of North Carolina, Life, University, Female, Athlete, Male, NIL, Longhorn, Learfield, Basketball, University of Georgia, Personality, University of Tennessee, Brock

AUSTIN, Texas, Jan. 30, 2024 /PRNewswire/ -- ZIPS "Car Wash Convos™" is back in Austin this week with another ride-along interview featuring Texas Longhorns Men's Basketball forward, Brock Cunningham.

Key Points: 
  • AUSTIN, Texas, Jan. 30, 2024 /PRNewswire/ -- ZIPS "Car Wash Convos™" is back in Austin this week with another ride-along interview featuring Texas Longhorns Men's Basketball forward, Brock Cunningham.
  • Brock's episode was filmed with his host, Texas alum, Ray Villareal, during a car wash at ZIPS in Austin and was released today on YouTube and Instagram.
  • "I love sharing more of my personality with Longhorn Nation and I'm proud to represent my team and my school in this unique approach to NIL," said Brock Cunningham, Texas Longhorns forward.
  • He is currently in his sixth season on the Texas Longhorns Men's Basketball team and has played in 113 career games.

GeneCentric Therapeutics Announces Upcoming Presentations at the American Society of Clinical Oncology Genitourinary Cancers Symposium and Precision Medicine World Conference

Retrieved on: 
Monday, January 22, 2024
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Genetics, Clinical Trials, Patient, Carcinoma, Therapy, University of North Carolina, RNA, ASCO, University, Society, Conference, Medicine, Pharmaceutical industry

GeneCentric Therapeutics , a company making precision medicine more precise through RNA-based diagnostics, today announced upcoming presentations at the Precision Medicine World Conference (PMWC) in Santa Clara, California from January 24-26 and the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), which will be held January 25-27 in San Francisco, California.

Key Points: 
  • GeneCentric Therapeutics , a company making precision medicine more precise through RNA-based diagnostics, today announced upcoming presentations at the Precision Medicine World Conference (PMWC) in Santa Clara, California from January 24-26 and the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), which will be held January 25-27 in San Francisco, California.
  • “We are encouraged to see the growing adoption of our signatures and tests by commercial reference labs and biopharma partners leading the way in precision oncology."
  • GeneCentric will present at PMWC, which was established in 2009 and is the largest annual conference dedicated to precision medicine.
  • GeneCentric’s presentations will highlight the use of transcriptomics in precision medicine and the development of RNA-based diagnostics.